All

API

FDF

Price

Services

Excipients

Enquiries

Find

Active Pharmaceutical Ingredients
Finished Drug Formulations
Price
Excipients
Services
Marketplace

Market Place

Post Enquiry

Grow Your Pharma Business Digitally

Scorr-Insert

X

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

A collaboration with SCORR Marketing

All Data

Filters

refresh

×

FILTER DATA :

News Type

Company

Product Type

Deal Size

Upfront Payment

refresh

Product Type

Companies

Ipsen

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

FRANCE France

Post An Enquiry

BIO International Convention

Participation Not Confirmed

Update your events

Ipsen Enters into an Option Agreement with IRICoR and University of Montreal for A Discovery-stage Oncology Program

Contact the Supplier

Lead Product(s): Undisclosed

Therapeutic Area: Oncology

Highest Development Status: Discovery Product Type: Undisclosed

Partner/Sponsor/Collaborator: University of Montreal

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Licensing Agreement May 04, 2020

Details:

University of Montreal/IRICoR will conduct and finance the research program until the license is exercised. Ipsen would assume all development activities and commercialize the drug candidate globally.